Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Biochemical and Biophysical Research Communications|January 21, 2021
Down regulation of U2AF1 promotes ARV7 splicing and prostate cancer progressionHongwen Cao, Dan Wang, Renjie Gao, et al.Aging|February 23, 2022
Qi Ling decreases paclitaxel resistance in the human prostate cancer by reversing tumor-associated macrophages functionHongwen Cao, Dan Wang, Renjie Gao, et al.Functional & Integrative Genomics|February 13, 2019
The RNA-binding protein FXR1 modulates prostate cancer progression by regulating FBXO4Hongwen Cao, Renjie Gao, Chao Yu, et al.Aging|October 6, 2021
Zhoushi Qi Ling decoction represses docetaxel resistance and glycolysis of castration-resistant prostate cancer via regulation of SNHG10/miR-1271-5p/TRIM66 axisHongwen Cao, Dan Wang, Peng Sun, et al.American Journal of Translational Research|September 20, 2021
Effects of Xialiqi capsules on rats with nonbacterial prostatitisHuiming Bai, Hongwen Cao, Dan Wang, et al.Global Medical Genetics|March 3, 2025
Role of agonistic autoantibodies to the angiotensin II type 1 receptor (AT1-AA) in pathogenesis of preeclampsiaJing Wang, Lijuan Shan, Yanhui Zhao, et al.Journal of Traditional and Complementary Medicine|January 15, 2024
Zhoushi Qi Ling decoction inhibits the progression of castration-resistant prostate cancer in vivo by regulating macrophage infiltration via IL6-STAT3 signalingHongwen Cao, Dan Wang, Renjie Gao, et al.Journal of Cancer|January 6, 2023
miR-143 mediates abiraterone acetate resistance by regulating the JNK/Bcl-2 signaling pathway in prostate cancerYigeng Feng, Hongwen Cao, Wenyang Zhao, et al.Frontiers in Medicine|December 25, 2025
Qiling decoction enhances the anti-tumor activity of abiraterone acetate by up-regulating miR-143 expression in abiraterone acetate-resistant prostate cancer cellsLizhi Chen, Hongwen Cao, Peng Sun, et al.Journal of Cancer|August 14, 2023
Zhoushi Qiling decoction inhibits proliferation of human prostate cancer cells through IL6/STAT3 pathwayHongwen Cao, Yigeng Feng, Peng Sun, et al.Pageof 4